Global Overactive Bladder Treatment Market, By Type (Mirabegron, Anticholinergics, Botox, Neuromodulation), Disease Type (Idiopathic Overactive Bladder Syndrome, Neurogenic Overactive Bladder Syndrome), and Region — Industry Analysis and Forecast to 2030
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Architecture
2.3 Scope of the Study
2.4 Related Stakeholders
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.2.1 Key Insights
3.2.2 Breakdown of Primary Interviews
3.3 Secondary Research
3.3.1 Important Sources
3.4 Market Size Estimation Approaches
3.4.1 Top-Down Approach
3.4.2 Bottom-Up Approach
3.4.3 Data Triangulation
3.5 List of Assumptions
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.3 Restraints
4.4 Opportunities
4.5 Challenges
4.6 Porter’s Five Forces Model Analysis
4.7 Value Chain Analysis
4.8 Regulatory Landscape
5 Global Overactive Bladder Treatment Market: Type
5.1 Introduction
5.2 Mirabegron
5.3 Anticholinergics
5.3.1 Solifenacin
5.3.2 Oxybutynin
5.3.3 Darifenacin
5.3.4 Fesoterodine
5.3.5 Tolterodine
5.3.6 Trospium
5.3.7 Other Anticholinergics
5.4 Botox
5.5 Neuromodulation
5.6 Other Treatments
6 Global Overactive Bladder Treatment Market: Disease Type
6.1 Introduction
6.2 Idiopathic Overactive Bladder Syndrome
6.3 Neurogenic Overactive Bladder Syndrome
6.3.1 Strokes
6.3.2 Parkinson’s Disease
6.3.3 Multiple Sclerosis
6.3.4 Spinal Cord Injuries
6.3.5 Other Disorders
7 Global Overactive Bladder Treatment Market: Regional Trends
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia-Pacific
7.4.1 China
7.4.2 India
7.4.3 Japan
7.4.4 South Korea
7.4.5 Rest of Asia-Pacific
7.5 Middle East and Africa
7.5.1 GCC Countries
7.5.2 South Africa
7.5.3 Rest of Middle East and Africa
7.6 Latin America
7.6.1 Brazil
7.6.2 Mexico
7.6.3 Argentina
7.6.4 Rest of Latin America
8 Competitive Landscape
8.1 Introduction
8.2 Vendor Evaluation Criteria
8.3 Vendor Share Analysis, 2023
8.4 Recent Developments, 2021-2023
8.4.1 New Product Launches
8.4.2 Partnerships
8.4.3 Mergers or Acquisitions
8.4.4 Business Expansions
9 Company Profiles
9.1 Astellas Pharma Inc.
9.2 Pfizer Inc.
9.3 Teva Pharmaceutical Industries Ltd.
9.4 Abbvie Inc.
9.5 Hisamitsu Pharmaceutical Co., Inc.
9.6 Viatris Inc.
9.7 Johnson & Johnson Services, Inc.
9.8 Endo Pharmaceuticals Inc.
9.9 Amneal Pharmaceuticals LLC
9.10 Lupin
9.11 Sun Pharmaceutical Industries Ltd.
9.12 Glenmark
9.13 Medtronic
9.14 Macleods Pharmaceuticals Ltd.
9.15 Ajanta Pharma
9.16 Granules India Limited
9.17 Apotex Inc.
9.18 Urovant Sciences
10 Appendix
10.1 Discussion Guide
10.2 Customization Options
10.3 Related Reports
List of Tables
Table 1 Global Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 2 Global Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 3 Global Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 4 Global Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 5 Global Overactive Bladder Treatment Market, By Region, 2023-2030 (USD Million)
Table 6 North America Overactive Bladder Treatment Market, By Country, 2023-2030 (USD Million)
Table 7 North America Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 8 North America Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 9 North America Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 10 North America Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 11 US Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 12 US Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 13 US Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 14 US Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 15 Canada Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 16 Canada Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 17 Canada Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 18 Canada Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 19 Europe Overactive Bladder Treatment Market, By Country, 2023-2030 (USD Million)
Table 20 Europe Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 21 Europe Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 22 Europe Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 23 Europe Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 24 Germany Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 25 Germany Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 26 Germany Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 27 Germany Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 28 UK Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 29 UK Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 30 UK Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 31 UK Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 32 France Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 33 France Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 34 France Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 35 France Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 36 Italy Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 37 Italy Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 38 Italy Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 39 Italy Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 40 Spain Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 41 Spain Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 42 Spain Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 43 Spain Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 44 Rest of Europe Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 45 Rest of Europe Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 46 Rest of Europe Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 47 Rest of Europe Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 48 Asia Pacific Overactive Bladder Treatment Market, By Country, 2023-2030 (USD Million)
Table 49 Asia Pacific Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 50 Asia Pacific Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 51 Asia Pacific Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 52 Asia Pacific Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 53 China Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 54 China Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 55 China Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 56 China Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 57 India Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 58 India Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 59 India Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 60 India Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 61 Japan Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 62 Japan Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 63 Japan Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 64 Japan Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 65 South Korea Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 66 South Korea Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 67 South Korea Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 68 South Korea Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 69 Rest of Asia Pacific Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 70 Rest of Asia Pacific Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 71 Rest of Asia Pacific Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 72 Rest of Asia Pacific Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 73 Middle East and Africa Overactive Bladder Treatment Market, By Country, 2023-2030 (USD Million)
Table 74 Middle East and Africa Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 75 Middle East and Africa Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 76 Middle East and Africa Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 77 Middle East and Africa Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 78 GCC Countries Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 79 GCC Countries Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 80 GCC Countries Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 81 GCC Countries Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 82 South Africa Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 83 South Africa Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 84 South Africa Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 85 South Africa Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 86 Rest of Middle East and Africa Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 87 Rest of Middle East and Africa Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 88 Rest of Middle East and Africa Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 89 Rest of Middle East and Africa Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 90 Latin America Overactive Bladder Treatment Market, By Country, 2023-2030 (USD Million)
Table 91 Latin America Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 92 Latin America Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 93 Latin America Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 94 Latin America Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 95 Brazil Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 96 Brazil Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 97 Brazil Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 98 Brazil Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 99 Mexico Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 100 Mexico Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 101 Mexico Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 102 Mexico Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 103 Argentina Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 104 Argentina Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 105 Argentina Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 106 Argentina Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
Table 107 Rest of Latin America Overactive Bladder Treatment Market, By Type, 2023-2030 (USD Million)
Table 108 Rest of Latin America Overactive Bladder Treatment Market, By Anticholinergics, 2023-2030 (USD Million)
Table 109 Rest of Latin America Overactive Bladder Treatment Market, By Disease Type, 2023-2030 (USD Million)
Table 110 Rest of Latin America Overactive Bladder Treatment Market, By Neurogenic Overactive Bladder Syndrome, 2023-2030 (USD Million)
List of Figures
Figure 1 Global Overactive Bladder Treatment Market: Market Segmentation
Figure 2 Global Overactive Bladder Treatment Market: Research Methodology
Figure 3 Breakdown of Primary Interviews
Figure 4 Top Down Approach
Figure 5 Bottom Up Approach
Figure 6 Data Triangulation
Figure 7 Global Overactive Bladder Treatment Market: Drivers, Restraints, Opportunities, and Challenges
Figure 8 Global Overactive Bladder Treatment Market: Porter’s Five Forces Model Analysis
Figure 9 Global Overactive Bladder Treatment Market: Value Chain Analysis
Figure 10 Global Overactive Bladder Treatment Market Share Analysis, By Type, 2023 and 2030
Figure 11 Global Overactive Bladder Treatment Market Share Analysis, By Anticholinergics, 2023 and 2030
Figure 12 Global Overactive Bladder Treatment Market Share Analysis, By Disease Type, 2023 and 2030
Figure 13 Global Overactive Bladder Treatment Market Share Analysis, By Neurogenic Overactive Bladder Syndrome, 2023 and 2030
Figure 14 Global Overactive Bladder Treatment Market Share Analysis, By Region, 2023 and 2030
Figure 15 North America Overactive Bladder Treatment Market Share Analysis, By Country, 2023 and 2030
Figure 16 North America Overactive Bladder Treatment Market Share Analysis, By Type, 2023 and 2030
Figure 17 North America Overactive Bladder Treatment Market Share Analysis, By Anticholinergics, 2023 and 2030
Figure 18 North America Overactive Bladder Treatment Market Share Analysis, By Disease Type, 2023 and 2030
Figure 19 North America Overactive Bladder Treatment Market Share Analysis, By Neurogenic Overactive Bladder Syndrome, 2023 and 2030
Figure 20 Europe Overactive Bladder Treatment Market Share Analysis, By Country, 2023 and 2030
Figure 21 Europe Overactive Bladder Treatment Market Share Analysis, By Type, 2023 and 2030
Figure 22 Europe Overactive Bladder Treatment Market Share Analysis, By Anticholinergics, 2023 and 2030
Figure 23 Europe Overactive Bladder Treatment Market Share Analysis, By Disease Type, 2023 and 2030
Figure 24 Europe Overactive Bladder Treatment Market Share Analysis, By Neurogenic Overactive Bladder Syndrome, 2023 and 2030
Figure 25 Asia Pacific Overactive Bladder Treatment Market Share Analysis, By Country, 2023 and 2030
Figure 26 Asia Pacific Overactive Bladder Treatment Market Share Analysis, By Type, 2023 and 2030
Figure 27 Asia Pacific Overactive Bladder Treatment Market Share Analysis, By Anticholinergics, 2023 and 2030
Figure 28 Asia Pacific Overactive Bladder Treatment Market Share Analysis, By Disease Type, 2023 and 2030
Figure 29 Asia Pacific Overactive Bladder Treatment Market Share Analysis, By Neurogenic Overactive Bladder Syndrome, 2023 and 2030
Figure 30 Middle East and Africa Overactive Bladder Treatment Market Share Analysis, By Type, 2023 and 2030
Figure 31 Middle East and Africa Overactive Bladder Treatment Market Share Analysis, By Anticholinergics, 2023 and 2030
Figure 32 Middle East and Africa Overactive Bladder Treatment Market Share Analysis, By Disease Type, 2023 and 2030
Figure 33 Middle East and Africa Overactive Bladder Treatment Market Share Analysis, By Neurogenic Overactive Bladder Syndrome, 2023 and 2030
Figure 34 Latin America Overactive Bladder Treatment Market Share Analysis, By Type, 2023 and 2030
Figure 35 Latin America Overactive Bladder Treatment Market Share Analysis, By Anticholinergics, 2023 and 2030
Figure 36 Latin America Overactive Bladder Treatment Market Share Analysis, By Disease Type, 2023 and 2030
Figure 37 Latin America Overactive Bladder Treatment Market Share Analysis, By Neurogenic Overactive Bladder Syndrome, 2023 and 2030
Figure 38 Global Overactive Bladder Treatment Market, By Competitive Benchmarking
Figure 39 Global Overactive Bladder Treatment Market, By Vendor Share Analysis, 2023
PRICE
ASK FOR FREE SAMPLE REPORT